Eli Casdin

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
7 years
Director since
2023

7 years of board service in total across 2 boards, counting each seat separately. Longest: GeneDx Holdings Corp., 3 years.

3 years · Since 2023
3 years · Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jun 18, 2026 Standard BioTools Inc. Grant or award +99,116 — —
Jun 18, 2026 GeneDx Holdings Corp. Option exercise +3,576 — —
Jun 5, 2026 GeneDx Holdings Corp. Open-market purchase +50,000 $52.86 $2,643,000
Jun 4, 2026 GeneDx Holdings Corp. Open-market purchase +150,000 $56.44 $8,466,000
Feb 26, 2026 Standard BioTools Inc. Grant or award +52,991 $1.17 $61,999
Nov 20, 2025 Standard BioTools Inc. Open-market purchase +450,000 $1.30 $585,000
Nov 19, 2025 Standard BioTools Inc. Open-market purchase +350,000 $1.28 $448,000
Nov 18, 2025 Standard BioTools Inc. Open-market purchase +275,000 $1.23 $338,250
Sep 4, 2025 Standard BioTools Inc. Open-market purchase +250,000 $1.28 $320,000
Sep 3, 2025 Standard BioTools Inc. Open-market purchase +250,000 $1.27 $317,500
Aug 22, 2025 GeneDx Holdings Corp. Open-market sale −500,000 $120.90 $60,450,000
Aug 15, 2025 Standard BioTools Inc. Open-market purchase +150,000 $1.22 $183,000
Aug 14, 2025 Standard BioTools Inc. Open-market purchase +133,220 $1.21 $161,196
Aug 13, 2025 Standard BioTools Inc. Open-market purchase +75,000 $1.31 $98,250
Aug 11, 2025 BioLife Solutions Inc. Open-market sale −500,000 $22.60 $11,300,000

Questions about Eli Casdin

What boards is Eli Casdin on?

Eli Casdin sits on the boards of GeneDx Holdings Corp. and Standard BioTools Inc.

How long has Eli Casdin served on boards?

Our records show at least 7 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.